NCT02153931

Brief Summary

Background: \- Studies show that Internet Support Groups (ISGs) can help parents of children with chronic conditions. Researchers want to find out if ISGs can help parents of a child with the genetic disorder Neurofibromatosis Type 1 (NF1). Objective: \- To see if an ISG for parents with a child with NF1 can give the parents more social support and less anxiety. Eligibility: \- Adults age 18 and older with a child (age 0 25 years) with NF1. Design:

  • Participants will register for the study on a website hosted by the Children s Tumor Foundation.
  • Participants will complete 5 questionnaires. These will be about their emotional well-being, their child s health status, and their contact information.
  • The ISG will include a Discussion Forum that participants can enter 24 hours a day, 7 days a week. A professional moderator will post questions and discussion topics. The moderator can also respond to questions. They will be a psychologist, a psychology associate, or a nurse-practitioner. Each one will be highly experienced at working with young people with NF1 and their families.
  • The ISG also will contain a chat room. Here participants can chat with other users in real time. The chat room will be open for one 90-minute session per week.
  • The ISG will remain open for 8 weeks. Then participants will retake 4 of the questionnaires from the beginning of the study. They will also complete 1 other questionnaire about their experiences with the ISG. Information from any messages participants post on the ISG website will be collected.
  • Three months after the ISG closes, participants will complete the questionnaires one final time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2014

Completed
Same day until next milestone

Study Start

First participant enrolled

May 31, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 3, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 6, 2015

Completed
3.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2019

Completed
Last Updated

January 31, 2019

Status Verified

January 29, 2019

Enrollment Period

10 months

First QC Date

May 31, 2014

Last Update Submit

January 30, 2019

Conditions

Keywords

Children's Tumor FoundationSocial SupportOnlineAnxietyDepression

Outcome Measures

Primary Outcomes (1)

  • ISG effects on perceived support

    To determine the effects of an ISG on perceived social support among parents of a child with NF1 from baseline to 8 weeks and frombaseline to 3 months postintervention.

    3 months

Secondary Outcomes (2)

  • ISG effects on depression and anxiety

    3 months

  • Identify themes and needs of chat room support

    2 years

Study Arms (1)

Volunteers

Parents of children with NF1

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must self-report being the primary caregiver of one or more children ages 0 to 25 with a confirmed diagnosis of NF1.
  • Participants must report being at least 18 years of age.
  • Participants must report living in the same home as the child(ren) with NF1 a majority of the time.
  • Participants must report having regular access to a computer and internet connection.
  • Participants will indicate they do not have any plans to start any other internet support group for parents of children with NF during the study time period.
  • Participants must have the ability to read and communicate in the English language.
  • Participants must have the ability to understand and the willingness to provide an online informed consent document.

You may not qualify if:

  • Although individuals will be allowed to participate if they currently are part of another internet forum for NF, they will be excluded if they report they plan to start a new internet support group during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

MeSH Terms

Conditions

Neurofibromatosis 1Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

NeurofibromatosesNeurofibromaNerve Sheath NeoplasmsNeoplasms, Nerve TissueNeoplasms by Histologic TypeNeoplasmsNeoplastic Syndromes, HereditaryNeurocutaneous SyndromesNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Staci M Peron, Ph.D.

    National Cancer Institute (NCI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2014

First Posted

June 3, 2014

Study Start

May 31, 2014

Primary Completion

April 6, 2015

Study Completion

January 29, 2019

Last Updated

January 31, 2019

Record last verified: 2019-01-29

Locations